证券记录 · 已归档季度
EW
Edwards Lifesciences Corporation · Healthcare · Medical - Devices
23被追踪持有人
0Δ持有人
232.09M持有股份
$18.15B报告持仓市值
+0新建仓位
−0清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 -3.8% · 净新建仓位 0.0% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 14.87M | $1.28B | n/a | n/a |
| Q2 2026 | 163 | -6 | 423.46M | $38.23B | +2 | −9 |
| Q1 2026 | 173 | +2 | 408.99M | $32.75B | +6 | −5 |
| Q4 2025 | 170 | 0 | 441.50M | $37.63B | +2 | −1 |
| Q3 2025 | 24 | -1 | 280.60M | $21.82B | +1 | −3 |
| Q2 2025 | 23 | 0 | 232.09M | $18.15B | n/a | n/a |
| Q1 2025 | 20 | -1 | 112.98M | $8.18B | n/a | −1 |
| Q4 2024 | 21 | +1 | 116.40M | $8.61B | +1 | n/a |
| Q3 2024 | 19 | +1 | 77.58M | $5.12B | +2 | −1 |
| Q2 2024 | 18 | n/a | 60.09M | $5.55B | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 70.00M | n/a | $5.47B | 0.1% | n/c | 1 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (被动) | 55.65M | n/a | $4.35B | 0.1% | n/c | 1 | SEC ↗ ×21 |
| 3 | State Street Global Advisors ✦ (被动) | 25.63M | -0.6% | $2.00B | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 19.83M | -31.9% | $1.55B | 0.3% | ▼ Trim | 5 | SEC ↗ ×9 |
| 5 | Citadel Advisors ✦ | 12.73M | -4.9% | $995.71M | 0.9% | ▼ Trim | 5 | SEC ↗ ×2 |
| 6 | Geode Capital Management ✦ (被动) | 12.72M | +0.4% | $990.07M | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | Norges Bank ✦ (被动) | 7.42M | +14.4% | $580.64M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 8 | Marshall Wace ✦ | 6.90M | +127.5% | $539.30M | 0.6% | ▲ Add | 5 | SEC ↗ ×3 |
| 9 | Millennium Management ✦ | 6.68M | +94.0% | $522.60M | 0.5% | ▲ Add | 5 | SEC ↗ |
| 10 | PRIMECAP Management ✦ | 3.45M | +49.9% | $269.58M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 3.04M | +106.9% | $237.71M | 0.6% | ▲ Add | 3 | SEC ↗ |
| 12 | Fidelity (FMR) ✦ | 2.53M | n/a | $197.71M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 13 | Renaissance Technologies ✦ | 1.04M | +3.4% | $81.37M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 970.21K | +5.6% | $75.88M | 0.1% | ▲ Add | 5 | SEC ↗ ×6 |
| 15 | Adage Capital Partners ✦ | 873.82K | +92.8% | $68.34M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 860.09K | +0.1% | $67.27M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 17 | Baillie Gifford ✦ | 582.60K | +0.2% | $45.56M | 0.0% | ▲ Add | 5 | SEC ↗ ×4 |
| 18 | Bridgewater Associates ✦ | 444.92K | +611.6% | $34.80M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 19 | Fisher Asset Management ✦ | 316.39K | -96.9% | $24.75M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 20 | D. E. Shaw & Co. ✦ | 171.20K | -80.4% | $13.39M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 21 | Arrowstreet Capital ✦ | 153.87K | -42.2% | $12.03M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 22 | Two Sigma Investments ✦ | 54.36K | -44.0% | $4.25M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 23 | Gotham Asset Management ✦ | 43.30K | -0.8% | $3.39M | 0.0% | ▼ Trim | 5 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 4 持有人, 229.24K 股份, $319,498 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Oct 08
Lippis Daniel J.
Officer · 619 股 · $53,017
Sep 11
Lippis Daniel J.
Officer · 619 股 · $54,169
Aug 31
Dahl Andrew M.
Officer · 544 股 · $49,534
Aug 28
Bruls Annette
Officer · 2.64K 股 · $237,907
Aug 26
Markowitz Wayne
Officer · 1.24K 股 · $113,417
Aug 26
Chopra Daveen
Officer · 1.15K 股 · $105,893
Aug 26
Chopra Daveen
Officer · 30.65K 股 · $2.79M
Aug 11
Lippis Daniel J.
Officer · 619 股 · $56,967
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据